AppliedVR
Josh Sackman, president and cofounder of AppliedVR, provides MobiHealthNews with an overview of the medical XR space. He focuses on the challenges and progress in the sector.
Highmark members with low back pain can now get a prescription for the VR company's FDA-cleared RelieVRx.
From the end of the Public Health Emergency to the launch of ChatGPT and the Apple Vision Pro, executives reflect on what stood out to them this year.
The award will support veterans' access to the California-based virtual reality company's FDA-authorized at-home chronic low back pain offering, RelieVRx.
Leaders in digital health foresee investors having a high bar for funding in 2024, looking toward companies with proven modalities and a clear pathway to profitability.
Digital health stakeholders said that AI will be used next year to help ease administrative tasks for providers, improve clinical trial participation and increase transparency in healthcare.
Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.
Josh Sackman, president and cofounder of AppliedVR, discusses the new Healthcare Common Procedure Coding System (HCPSC) Level II code for the company's product RelieVRx.
The study was supported by AppliedVR and used its system for treating chronic lower-back pain. The tool received FDA De Novo clearance last year.
Also: Pear Therapeutics joins EHR vendor Epic's App Orchard, and AppliedVR changes the name of its flagship therapeutic.